KariE(Reuter)RobertsMD
Pulmonology • Boston, MACritical Care Medicine, Pulmonary Vascular Medicine
Vice President for Education, Tufts Medicine Associate Chief Medical Officer for Graduate Medical Education (DIO), Tufts Medical Center Academic Dean and Associate Professor, Medicine, Tufts University School of Medicine
Dr. Roberts is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
800 Washington St
# 257
Boston, MA 02111Phone+1 617-636-5513Fax+1 617-636-5953
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Pulmonary Disease and Critical Care Medicine, 2000 - 2003
Johns Hopkins UniversityResidency, Internal Medicine, 1997 - 2000- Johns Hopkins University School of MedicineClass of 1997
Dartmouth CollegeBA, Biology, Environmental Studies, Cum Laude, 1988 - 1992
Certifications & Licensure
MA State Medical License 2004 - 2026
NY State Medical License 2000 - 2005- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
Clinical Trials
- A Study of Aspirin and Simvastatin in Pulmonary Arterial Hypertension Start of enrollment: 2006 Sep 01
- Preventing ICU Subsyndromal Delirium Conversion to Delirium With Haloperidol Start of enrollment: 2010 Sep 01
Publications & Presentations
PubMed
- 22 citationsComparison of acute hemodynamic effects of inhaled nitric oxide and inhaled epoprostenol in patients with pulmonary hypertension.Ioana R. Preston, Kristen D. Sagliani, Kari E. Roberts, Archan Shah, Shilpa A DeSouza
Pulmonary Circulation. 2013-01-01 - 60 citationsBone Morphogenetic Protein 9 Is a Mechanistic Biomarker of Portopulmonary Hypertension.Ivana Nikolic, Lai Ming Yung, Peiran Yang, Rajeev Malhotra, Samuel D Paskin-Flerlage
American Journal of Respiratory and Critical Care Medicine. 2019-04-01 - 154 citationsBMPR2 mutations in pulmonary arterial hypertension with congenital heart diseaseKari E. Roberts, J.J. McElroy, W.P.K. Wong, Elizabeth Yen, Allison C. Widlitz
The European Respiratory Journal. 2004-09-01
Journal Articles
- Serum Biomarker for Diagnostic Evaluation of Pulmonary Arterial Hypertension in Systemic SclerosisHarrison W Farber, Kari Roberts, Nicholas Hill, Robyn Domsic, Robert W Simms, BioMed Central
- Lower DHEA-S Levels Predict Disease and Worse Outcomes in Post-Menopausal Women with Idiopathic, Connective Tissue Disease- and Congenital Heart Disease-Associated Pul...Mary Whittenhall, Andrew E Foderaro, Jason S Fritz, Nicholas S Hill, Ioana R Preston, Pamela Ouyang, Harold I Palevsky, Kari E Roberts, K Akaya Smith, Steven M Kawut, ..., The European Respiratory Journal
Grant Support
- Heme Oxygenase Polymorphisms And Hepatopulmonary SyndromeNational Heart, Lung, And Blood Institute2008–2012
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
